Irvington, NJ, United States of America

Taras Durbak

This inventor holds 2 USPTO granted patents. Top assignee: Bristol-Myers Company. Active years: 1976-1980.


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 128(Granted Patents)


Company Filing History:


Years Active: 1976-1980

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Taras Durbak

Introduction

Taras Durbak is a notable inventor based in Irvington, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of compositions that enhance various products. With a total of 2 patents to his name, Durbak's work reflects a commitment to innovation and practical applications.

Latest Patents

Durbak's latest patents include a suspension composition of benzocaine and hair dressing compositions containing a hair substantive quaternary resin. The suspension composition features a therapeutically effective amount of powdered benzocaine suspended in an essentially anhydrous carrier, along with a copolymer of vinylpyrrolidone and an alpha-olefin to suppress crystal growth. The hair dressing composition is designed to impart hair-holding properties when applied, utilizing a grooming agent that is preferably incompatible with the quaternary resin.

Career Highlights

Taras Durbak is currently associated with Bristol-Myers Company, where he continues to innovate and contribute to the field. His work has been instrumental in developing products that enhance consumer experiences in personal care and pharmaceuticals.

Collaborations

Durbak has collaborated with notable coworkers, including Ara Nersesian and Fred Hubner, who have contributed to his projects and innovations.

Conclusion

Taras Durbak's inventive spirit and dedication to his craft have led to significant advancements in product formulations. His contributions are a testament to the impact of innovation in improving everyday products.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…